| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.3 | 0.08 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.32 | 0.09 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.088 | 0.09 |